Prawo i regulacje · 05/11/1996

DEA Schedules Remifentanil as Schedule II Narcotic Substance

The Drug Enforcement Administration has placed remifentanil and its salts into Schedule II of the Controlled Substances Act, imposing strict regulatory controls and criminal sanctions on its manufacture, distribution, and use, following its recent FDA approval as an intravenous pain reliever.